About Us

Our mission: develop first-in-class medications that will significantly impact the lives of patients with autoimmune disorders, chronic inflammatory diseases, and cancer.

Athos stands for:

Athos-A

A

Autoimmune Diseases

Athos-T

T

Technology

Machine Learning

Athos-H

H

Health

Patient Focus

Athos-O

O

Objectivity

Athos-S

S

Science

Founders

Led by a world class management and advisory team with complementary expertise in the pathobiology of autoimmune diseases, computational biology, medicinal chemistry, drug development, clinical trial design, and regulatory strategy. We believe the solution to complex diseases requires a system based approach.

Scientific Board Member

Senior Management

Athos Therapeutics is led by a world-class management team with a strong pharma, business and academic record in therapeutic drug development.

Chief Business Officer

Chief Medical Officer

VP, Medicinal Chemistry

VP, Computational Modeling

VP, Animal Modeling

VP, Analytical Chemistry

Scientific Advisory Board

The Athos Therapeutics Scientific Advisory Board (SAB) is comprised of an unrivaled, international group of world-renowned leaders who are experts in the fields of immunology, inflammatory bowel diseases, drug discovery and development. They are providing strategic and scientific advice to the Athos management team in order to guide the development of our innovative therapeutic programs for autoimmune diseases.

Cleveland Clinic
Cleveland, USA

University of Chicago
Chicago, USA

Icahn School of Medicine at Mount Sinai
New York, USA

Catholic University of Leuven
Leuven, Belgium

UCLA
Los Angeles, USA

RABIN MEDICAL CENTER
PETAH TIKVA, ISRAEL

Humanitas University
Milan, Italy

Hospital Clinic
Barcelona, Spain

Board of Directors

CHAIRMAN OF THE BOARD

Member of the Board

MEMBER OF THE BOARD

Member of the Board